LRRC8A Antibodies

Santa Cruz Biotechnology features a diverse variety of LRRC8A monoclonal antibodies for research focused on understanding LRRC8A protein functions. LRRC8A monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LRRC8A, a member of the leucine-rich repeat-containing protein family, plays a crucial role in forming volume-regulated anion channels, which are essential for maintaining cellular homeostasis and regulating cell volume. LRRC8A is involved in various physiological processes, including cell signaling and apoptosis, making it a significant target for research in cellular biology and disease mechanisms. Research focused on LRRC8A can provide insights into its implications in pathologies such as cancer and neurological disorders. Studying LRRC8A expression patterns helps researchers understand cellular responses to volume changes and osmotic stress. Investigating LRRC8A interactions with other proteins reveals new pathways in cell volume regulation. Exploring LRRC8A's role in disease progression opens possibilities for therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies for LRRC8A support researchers worldwide in advancing scientific understanding of cellular volume regulation and disease mechanisms.